| BCBS Oklahoma Medical Policies | Ambulatory or Video Electroencephalogram (EEG) Monitoring, | 2024-07-15 |
| BCBS Oklahoma Medical Policies | Continuous Passive Motion (CPM) Device | 2024-07-15 |
| BCBS Oklahoma Medical Policies | FDA-Approved Drugs, Biologicals, Cellular and Gene Therapies | 2024-07-15 |
| BCBS Oklahoma Medical Policies | Hematopoietic Cell Transplantation for Acquired | 2024-07-15 |
| BCBS Oklahoma Medical Policies | Hematopoietic Cell Transplantation for Malignant | 2024-07-15 |
| BCBS Oklahoma Medical Policies | Immune Cellular Function Assay to Monitor and Predict | 2024-07-15 |
| BCBS Oklahoma Medical Policies | Temporarily Implanted Prostatic Stents for Benign Prostatic | 2024-07-15 |
| BCBS Oklahoma Medical Policies | Three-dimensional (3D), Four-dimensional (4D), and Five- | 2024-07-15 |
| BCBS Oklahoma Medical Policies | Topographic Brain Mapping (Quantitative | 2024-07-15 |
| BCBS Oklahoma Medical Policies | Total Ankle Replacement (TAR) | 2024-07-15 |